Skip to main content
logo
Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
544.52
+2.83 (0.52%)
At close: Aug 31, 2026, 4:00 PM EDT
545.80
+1.28 (0.24%)
After-hours: Aug 31, 2026, 7:58 PM EDT

Vertex Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Equivalents
6,1445,4935,0854,9404,9724,6754,5705,2394,5809,15810,36911,11010,1519,29010,5049,1728,7027,6006,7956,276
Short-Term Investments
1,7091,7541,5231,3471,4111,5271,5461,2851,2151,013849.28181,0851,124274.5599.2551.2638729.9685.19
Cash & Short-Term Investments
7,8527,2476,6086,2876,3836,2016,1166,5255,79610,17111,21811,92811,23610,41410,7799,7719,2538,2387,5256,961
Cash Growth (YoY)
23.02%16.86%8.05%-3.64%10.13%-39.03%-45.48%-45.30%-48.42%-2.33%4.08%22.08%21.43%26.41%43.24%40.37%37.95%18.98%13.00%13.17%
Accounts Receivable
2,1341,9962,0531,9461,8941,8051,6091,7511,6561,7931,5631,5391,5561,5481,4421,3851,3331,2931,1371,100
Receivables
2,1341,9962,0531,9461,8941,8051,6091,7511,6561,7931,5631,5391,5561,5481,4421,3851,3331,2931,1371,100
Inventory
1,7651,7671,6871,6271,4991,3601,2051,080914.6813.1738.8688.7603.5535.1460.6388.2367.7338.9353.1333.46
Prepaid Expenses
720.5672.7736.2694.5639.9581.6459.2438.7528.5473.4537.6496467.8443.5431.6529.8428.7430.4442.1419.01
Restricted Cash
10.612-8.29.810.7-8.910.911.4-6.42.35.7-5.51.93.95.14.52
Other Current Assets
60.836.1117.16.72.650.5206.51.63626.386.137.86.819.5121.9191.6118.957.298.634.3
Total Current Assets
12,54411,73011,20110,57010,42810,0099,5969,8048,94213,28914,14414,69613,87312,96613,23512,27111,50410,3619,5618,853
Property, Plant & Equipment
3,3283,2943,0833,0172,6492,6342,5852,5141,7711,4861,4531,4351,4471,4481,4561,4611,4181,4361,4241,355
Long-Term Investments
5,8695,8315,7945,8045,7125,2215,1734,7784,4784,4562,4981,7991,4561,180112.298.695.885.8-35.9
Goodwill
1,0881,0881,0881,0881,0881,0881,0881,0881,0881,0881,0881,0881,0881,0881,0881,0751,0021,0021,0021,002
Other Intangible Assets
412.8418.5424.2429.8435.5441.2825.9831.6837.5834.9839.9603.6603.6603.6603.6603.6387400400400
Long-Term Deferred Tax Assets
3,0112,9482,8982,9372,7122,5442,3312,3092,1861,9631,8121,7291,5381,3601,2471,1631,144945.5934.5933.84
Long-Term Deferred Charges
--66.6---62.6---58.9---40.2-----
Other Long-Term Assets
1,1711,1751,0891,0171,012942.6871.9916.1830.3801.4836.4376.6344.1328.9369.433.931.524.9110.839.62
Total Assets
27,42326,48425,64324,86224,03722,88122,53322,24020,13223,91722,73021,72620,34918,97418,15116,70615,58214,25613,43312,619

Liabilities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Accounts Payable
429.5489.3461.7420.3442.3445413395.8327.9351.4364.9375.9363323.2303.9126.9198173.6195127.86
Accrued Expenses
3,1792,9842,7823,6143,2712,9522,5843,2202,9402,7962,5562,9072,5982,3262,0032,2642,1201,7211,4671,585
Current Portion of Leases
--82.8---92.371.2--83.7---89.4---80.2-
Current Income Taxes Payable
--103.1---161.1---99.5---123.3---211.3-
Current Unearned Revenue
157218.7171.8182146.9228.4206.8220128.3275.8170.3157.1179.1236.4159.6119.5134.8186.1171.7104.1
Other Current Liabilities
172.4188.4259.7259.5278.5158107.466.4151372.8273.2159.1211.9140.662.598.5103.910016.597.31
Total Current Liabilities
3,9383,8813,8614,4754,1383,7833,5653,9733,5473,7963,5473,5993,3523,0262,7422,6092,5562,1802,1421,914
Long-Term Leases
1,9781,9871,9531,8351,5271,6491,6571,703933.4721.3724.7744.7767.6789.2810.3824.6847.3872.5887.2876.8
Other Long-Term Liabilities
1,2601,2551,1631,2331,196951.9901.8933.3876.8853.6877.7869.3759.3726.5685.8242.9245.2296.4303.3296.97
Total Liabilities
7,1757,1236,9777,5446,8616,3846,1246,6095,3575,3715,1505,2134,8794,5424,2383,6773,6493,3493,3333,088

Shareholders' Equity

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Common Stock
2.52.52.52.52.62.62.62.62.62.62.62.62.62.62.62.62.62.62.52.56
Additional Paid-In Capital
4,5064,7435,1195,0125,9886,1736,6726,9067,1017,2857,4507,3407,3697,2207,3877,2267,1006,9306,8817,086
Retained Earnings
15,69114,59113,56012,36911,28610,2539,6078,6947,64811,24210,1429,1748,1387,2236,5235,7044,7733,9633,2012,431
Comprehensive Income & Other
48.524.8-15.9-64.5-101.168.1127.828.822.517.3-14.3-3-39.8-13.10.897.657.511.315.911.54
Total Common Equity
20,24819,36218,66617,31917,17516,49616,41015,63114,77518,54717,58016,51315,47014,43213,91313,03011,93410,90710,1009,531
Shareholders' Equity
20,24819,36218,66617,31917,17516,49616,41015,63114,77518,54717,58016,51315,47014,43213,91313,03011,93410,90710,1009,531
Total Liabilities & Equity
27,42326,48425,64324,86224,03722,88122,53322,24020,13223,91722,73021,72620,34918,97418,15116,70615,58214,25613,43312,619

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Total Debt
1,9781,9872,0361,8351,5271,6491,7501,774933.4721.3808.4744.7767.6789.2899.7824.6847.3872.5967.4876.8
Net Cash (Debt)
11,66411,01010,28410,17510,5019,7099,4749,4549,25513,83112,90812,88411,82610,7069,9918,9468,4067,3666,5586,084
Net Cash Growth (YoY)
11.07%13.41%8.55%7.63%13.46%-29.81%-26.60%-26.62%-21.74%29.19%29.19%44.01%40.68%45.36%52.36%47.04%44.58%22.25%14.71%8.56%
Net Cash Per Share
45.7042.9640.1639.5040.5637.4136.3736.2235.8652.9749.4749.4445.4141.1338.3834.4732.4928.5625.5223.43
Filing Date Shares Outstanding
253.46253.81254.03253.72256.39256.8256.79257.53258.1258.05258.31257.68258.09257.55257.09256.69256.46255.76254.58254.25
Total Common Shares Outstanding
253.35254.16253.99253.95256.29256.97256.94257.74258.02258.3257.7257.83257.79257.51257.01256.65256.03255.57254.48256.21
Working Capital
8,6067,8507,3406,0946,2906,2266,0325,8315,3949,49310,59711,09610,5219,94010,4939,6628,9478,1817,4196,938
Book Value Per Share
79.9276.1873.4968.2067.0164.2063.8760.6557.2671.8068.2264.0560.0156.0554.1350.7746.6142.6839.6937.20
Tangible Book Value
18,74717,85517,15415,80115,65214,96714,49613,71112,84916,62415,65314,82113,77912,74112,22111,35110,5449,5058,6988,129
Tangible Book Value Per Share
74.0070.2567.5462.2261.0758.2556.4253.2049.8064.3660.7457.4853.4549.4847.5544.2341.1837.1934.1831.73
Land
--33.1---33.1---33.1---33.1---33.1-
Buildings
--483.8---461.2---928.6---903.1---892.5-
Machinery
--1,198---1,061---911.9---788.6---701-
Leasehold Improvements
--1,009---737.6---474.6---410.9---363.5-
SEC Filings: 10-K · 10-Q